You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Details for Patent: 9,833,458


✉ Email this page to a colleague

« Back to Dashboard


Title:Thioflavin derivatives for use in the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
Abstract: This invention relates to novel thioflavin derivatives, methods of using the derivatives in, for example, in vivo imaging of patients having neuritic plaques, pharmaceutical compositions comprising the thioflavin derivatives and method of synthesizing the compounds. The compounds find particular use in the diagnosis and treatment of patients having diseases where accumulation of neuritic plaques are prevalent. The disease states or maladies include but are not limited to Alzheimer's Disease, familial Alzheimer's Disease, Down's Syndrome and homozygotes for the apolipoprotein E4 allele.
Inventor(s): Klunk; William E. (Pittsburgh, PA), Mathis, Jr.; Chester A. (Pittsburgh, PA), Wang; Yanming (Beachwood, OH)
Assignee: University of Pittsburgh--Of the Commonwealth System of Higher Education (Pittsburgh, PA)
Filing Date:Jan 13, 2015
Application Number:14/595,949
Claims:1. A pharmaceutical composition comprising an amyloid binding compound and a pharmaceutically acceptable carrier, wherein the amyloid binding compound is represented by the following formula or a water soluble, non-toxic salt thereof: ##STR00063## wherein: Y is NR.sup.1R.sup.2; Z is S; and R.sup.1 is H; wherein R.sup.2 is selected from the group consisting of a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3 and R' is H or a lower alkyl group), CF.sub.3, CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), R.sub.ph, and (CH.sub.2).sub.nR.sub.ph (wherein n=1, 2, 3, or 4, and R.sub.ph represents an optionally substituted phenyl group); R.sup.3 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.4 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.5 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.6 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.7 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.8 is selected from the group consisting of H, F, Cl, Br, I, ethyl, propyl, butyl, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.9 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.10 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; wherein in the chelating group (with or without a chelated metal group) of the form W-L or V--W-L, V is selected from the group consisting of --COO--, --CO--, --CH.sub.2O-- and --CH.sub.2NH--; W is --(CH.sub.2).sub.n where n=0,1,2,3,4, or 5; and L is: ##STR00064## wherein M is selected from the group consisting of Tc and Re.

2. The composition of claim 1, wherein R.sub.ph, when substituted, is substituted with one or more members selected from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR' (wherein R' is H or a lower alkyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L, wherein V is selected from the group consisting of --COO--, --CO--, --CH.sub.2O-- and --CH.sub.2NH--; W is --(CH.sub.2).sub.n where n=0, 1, 2, 3, 4, or 5; and L is: ##STR00065## wherein M is selected from the group consisting of Tc and Re.

3. The composition of claim 1, wherein R.sup.2.dbd.CH.sub.3, R.sup.3-R.sup.7.dbd.H, R.sup.8.dbd.OH and R.sup.9-R.sup.10 are H.

4. The composition of claim 1, wherein R.sup.2.dbd.CH.sub.3 and R.sup.8 is selected from the group consisting of CN, ethyl, propyl, butyl, OH, OCH.sub.3 and NH.sub.2.

5. The composition of claim 4, wherein R.sup.3-R.sup.7 and R.sup.9-R.sup.10 are H.

6. The composition of claim 1, wherein the amyloid binding compound binds to A.beta. with a dissociation constant (K.sub.D) between about 0.0001 and about 10.0 .mu.M when measured by binding to synthetic A.beta. peptide or Alzheimer's Disease brain tissue.

7. A pharmaceutical composition comprising an amyloid binding compound and a pharmaceutically acceptable carrier, wherein the amyloid binding compound is represented by the following formula or a water soluble, non-toxic salt thereof: ##STR00066## wherein: Y is NR.sup.1R.sup.2; Z is S; R.sup.1 is H; wherein R.sup.2 is selected from the group consisting of a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3 and R' is H or a lower alkyl group), CF.sub.3, CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), R.sub.ph, and (CH.sub.2).sub.nR.sub.ph (wherein n=1, 2, 3, or 4 and R.sub.ph represents an optionally substituted phenyl group); R.sup.3 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.4 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.5 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.6 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.7 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.8 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.9 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; R.sup.10 is selected from the group consisting of H, F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR', R.sub.ph, CR'.dbd.CR'--R.sub.ph, C(R').sub.2--C(R').sub.2--R.sub.ph (wherein R' is H or a lower alkyl group and R.sub.ph represents an optionally substituted phenyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of a form W-L or V--W-L; wherein one of R.sup.3-R.sup.10 is the chelating group (with or without the chelated metal group) of the form W-L or V--W-L, wherein V is selected from the group consisting of --COO--, --CO--, --CH.sub.2O-- and --CH.sub.2NH--; W is --(CH.sub.2).sub.n where n=0, 1, 2, 3, 4, or 5; and L is: ##STR00067## wherein M is selected from the group consisting of Tc and Re.

8. The composition of claim 7, wherein R.sub.ph, when substituted, is substituted with one or more members selected from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR' (wherein R' is H or a lower alkyl group), a tri-alkyl tin, and a chelating group (with or without a chelated metal group) of the form W-L or V--W-L, wherein V is selected from the group consisting of --COO--, --CO--, --CH.sub.2O-- and --CH.sub.2NH--; W is --(CH.sub.2).sub.n where n=0, 1, 2, 3, 4, or 5; and L is: ##STR00068## wherein M is selected from the group consisting of Tc and Re.

9. The composition of claim 7, wherein R.sup.2.dbd.CH.sub.3 and R.sup.8 is selected from the group consisting of CN, CH.sub.3, OH, OCH.sub.3 and NH.sub.2.

10. The composition of claim 7, wherein R.sup.2 is selected from the group consisting of a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3 and R' is H or a lower alkyl group), CF.sub.3, CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), R.sub.ph, and CH.sub.2R.sub.ph (wherein R.sub.ph represents an optionally substituted phenyl group).

11. The composition of claim 10, wherein R.sub.ph, when substituted, is substituted with one or more members selected from the group consisting of F, Cl, Br, I, a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3), CF.sub.3, CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X, O--CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), CN, (C.dbd.O)--R', N(R').sub.2, NO.sub.2, (C.dbd.O)N(R').sub.2, O(CO)R', OR', SR', COOR' (wherein R' is H or a lower alkyl group), a tri-alkyl tin and a chelating group (with or without a chelated metal group) of the form W-L or V--W-L, wherein V is selected from the group consisting of --COO--, --CO--, --CH.sub.2O-- and --CH.sub.2NH--; W is --(CH.sub.2).sub.n where n=0, 1, 2, 3, 4, or 5; and L is: ##STR00069## wherein M is selected from the group consisting of Tc and Re.

12. The composition of claim 1, wherein R.sup.2 is selected from the group consisting of a lower alkyl group, (CH.sub.2).sub.nOR' (wherein n=1, 2, or 3 and R' is H or a lower alkyl group), CF.sub.3, CH.sub.2--CH.sub.2X, CH.sub.2--CH.sub.2--CH.sub.2X (wherein X=F, Cl, Br or I), R.sub.ph, and CH.sub.2R.sub.ph (wherein R.sub.ph represents an optionally substituted phenyl group).

13. The composition of claim 10, wherein the amyloid binding compound binds to A.beta. with a dissociation constant (K.sub.D) between about 0.0001 and about 10.0 .mu.M when measured by binding to synthetic A.beta. peptide or Alzheimer's Disease brain tissue.

14. The composition of claim 1, wherein the pharmaceutically acceptable carrier is selected from the group consisting of an aqueous solution, a non-toxic excipient, a salt, a preservative and a buffer.

15. The composition of claim 1, wherein the pharmaceutically acceptable carrier comprises ethanol.

16. The composition of claim 1, wherein the pharmaceutically acceptable carrier comprises an aqueous buffer.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.